| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Breast Neoplasms | 25 | 2022 | 1222 | 2.510 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 8 | 2024 | 156 | 2.200 |
Why?
|
| Membrane Proteins | 9 | 2024 | 918 | 1.620 |
Why?
|
| Plant Extracts | 5 | 2018 | 130 | 1.600 |
Why?
|
| Mammary Glands, Animal | 11 | 2022 | 76 | 1.530 |
Why?
|
| Estrogens | 6 | 2020 | 115 | 1.470 |
Why?
|
| Food Hypersensitivity | 8 | 2025 | 26 | 1.370 |
Why?
|
| Breast | 5 | 2024 | 191 | 1.350 |
Why?
|
| Rhodiola | 5 | 2018 | 15 | 1.340 |
Why?
|
| Mast Cells | 8 | 2025 | 51 | 1.290 |
Why?
|
| Epithelial Cells | 8 | 2022 | 410 | 1.240 |
Why?
|
| Gene Expression Regulation, Neoplastic | 7 | 2020 | 583 | 1.070 |
Why?
|
| Macrophages | 4 | 2024 | 1037 | 1.020 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 3 | 2024 | 345 | 0.910 |
Why?
|
| Mammary Glands, Human | 5 | 2019 | 56 | 0.900 |
Why?
|
| Milk, Human | 5 | 2026 | 99 | 0.880 |
Why?
|
| Phytotherapy | 3 | 2018 | 34 | 0.850 |
Why?
|
| Insulin-Like Growth Factor I | 2 | 2017 | 83 | 0.770 |
Why?
|
| DNA Methylation | 4 | 2020 | 302 | 0.760 |
Why?
|
| Biomarkers, Tumor | 6 | 2020 | 524 | 0.750 |
Why?
|
| Cell Proliferation | 11 | 2020 | 1036 | 0.750 |
Why?
|
| Wnt Signaling Pathway | 4 | 2024 | 86 | 0.750 |
Why?
|
| Receptors, Aryl Hydrocarbon | 1 | 2022 | 16 | 0.730 |
Why?
|
| Mammary Neoplasms, Animal | 3 | 2022 | 29 | 0.730 |
Why?
|
| Polychlorinated Biphenyls | 1 | 2022 | 39 | 0.720 |
Why?
|
| Mice | 29 | 2025 | 11114 | 0.690 |
Why?
|
| Tumor Suppressor Protein p53 | 6 | 2021 | 318 | 0.640 |
Why?
|
| Macrophage Activation | 1 | 2020 | 115 | 0.630 |
Why?
|
| Proteins | 2 | 2017 | 764 | 0.620 |
Why?
|
| Female | 42 | 2026 | 34031 | 0.610 |
Why?
|
| Environmental Exposure | 2 | 2020 | 226 | 0.580 |
Why?
|
| Receptors, Estrogen | 5 | 2020 | 130 | 0.570 |
Why?
|
| Tumor Necrosis Factor-alpha | 3 | 2024 | 603 | 0.570 |
Why?
|
| Animals | 33 | 2025 | 21333 | 0.570 |
Why?
|
| Antineoplastic Agents | 5 | 2018 | 644 | 0.560 |
Why?
|
| Interleukin-10 | 4 | 2025 | 164 | 0.560 |
Why?
|
| Early Growth Response Protein 2 | 1 | 2017 | 8 | 0.530 |
Why?
|
| Disease Models, Animal | 10 | 2025 | 2293 | 0.510 |
Why?
|
| Mice, Inbred BALB C | 11 | 2024 | 869 | 0.510 |
Why?
|
| Cell Line, Tumor | 10 | 2020 | 1566 | 0.500 |
Why?
|
| Transforming Growth Factor beta | 3 | 2017 | 181 | 0.490 |
Why?
|
| Mammaplasty | 2 | 2014 | 47 | 0.480 |
Why?
|
| Obesity | 5 | 2020 | 1273 | 0.470 |
Why?
|
| Immunoglobulin E | 6 | 2025 | 81 | 0.470 |
Why?
|
| Signal Transduction | 8 | 2025 | 3149 | 0.460 |
Why?
|
| Melanoma, Experimental | 1 | 2015 | 42 | 0.450 |
Why?
|
| Transcriptome | 6 | 2020 | 399 | 0.440 |
Why?
|
| Humans | 43 | 2026 | 65142 | 0.430 |
Why?
|
| Neoplasms, Glandular and Epithelial | 1 | 2014 | 15 | 0.420 |
Why?
|
| Energy Metabolism | 1 | 2017 | 399 | 0.420 |
Why?
|
| Mice, Knockout | 9 | 2025 | 2156 | 0.410 |
Why?
|
| Mass Spectrometry | 2 | 2026 | 295 | 0.410 |
Why?
|
| Leukocytes | 1 | 2014 | 105 | 0.410 |
Why?
|
| Phenols | 2 | 2018 | 77 | 0.400 |
Why?
|
| Inflammation | 4 | 2024 | 1187 | 0.390 |
Why?
|
| Glioblastoma | 1 | 2015 | 161 | 0.390 |
Why?
|
| Adiposity | 1 | 2013 | 89 | 0.390 |
Why?
|
| Progesterone | 3 | 2008 | 165 | 0.380 |
Why?
|
| Apoptosis | 4 | 2020 | 1100 | 0.370 |
Why?
|
| Endocrine Disruptors | 3 | 2022 | 78 | 0.350 |
Why?
|
| Brain Neoplasms | 1 | 2015 | 318 | 0.350 |
Why?
|
| Parabens | 2 | 2021 | 6 | 0.330 |
Why?
|
| Cytokines | 6 | 2025 | 952 | 0.330 |
Why?
|
| Glucose | 1 | 2013 | 476 | 0.330 |
Why?
|
| Interleukin-1 Receptor-Like 1 Protein | 3 | 2025 | 7 | 0.320 |
Why?
|
| Benzophenones | 2 | 2020 | 20 | 0.320 |
Why?
|
| Doxorubicin | 3 | 2016 | 98 | 0.310 |
Why?
|
| Prodrugs | 3 | 2016 | 36 | 0.310 |
Why?
|
| Cells, Cultured | 7 | 2021 | 2188 | 0.300 |
Why?
|
| Phosphorylcholine | 3 | 2016 | 45 | 0.300 |
Why?
|
| Sodium | 2 | 2026 | 59 | 0.280 |
Why?
|
| Triple Negative Breast Neoplasms | 3 | 2021 | 71 | 0.280 |
Why?
|
| Potassium | 2 | 2026 | 97 | 0.280 |
Why?
|
| Pregnancy | 6 | 2024 | 2374 | 0.280 |
Why?
|
| Interleukin-33 | 2 | 2025 | 19 | 0.270 |
Why?
|
| Tissue Culture Techniques | 2 | 2020 | 33 | 0.270 |
Why?
|
| Cell Respiration | 2 | 2018 | 21 | 0.270 |
Why?
|
| Lactation | 3 | 2026 | 78 | 0.260 |
Why?
|
| Cell Death | 1 | 2008 | 289 | 0.250 |
Why?
|
| beta Catenin | 3 | 2017 | 99 | 0.250 |
Why?
|
| Ion-Selective Electrodes | 1 | 2026 | 4 | 0.240 |
Why?
|
| Gene Expression Regulation | 5 | 2021 | 1630 | 0.240 |
Why?
|
| Immunohistochemistry | 4 | 2015 | 896 | 0.230 |
Why?
|
| Plant Roots | 2 | 2016 | 56 | 0.230 |
Why?
|
| Transcriptional Activation | 2 | 2016 | 197 | 0.220 |
Why?
|
| Spheroids, Cellular | 2 | 2016 | 28 | 0.210 |
Why?
|
| Receptors, Progesterone | 2 | 2015 | 110 | 0.210 |
Why?
|
| Interleukin-4 | 1 | 2024 | 147 | 0.210 |
Why?
|
| bcl-2-Associated X Protein | 2 | 2014 | 48 | 0.210 |
Why?
|
| Intestines | 3 | 2020 | 178 | 0.200 |
Why?
|
| Antibodies, Neutralizing | 2 | 2024 | 217 | 0.200 |
Why?
|
| Mammary Neoplasms, Experimental | 2 | 2022 | 55 | 0.200 |
Why?
|
| Apoptosis Regulatory Proteins | 2 | 2014 | 152 | 0.200 |
Why?
|
| Diet, High-Fat | 2 | 2014 | 180 | 0.190 |
Why?
|
| Proto-Oncogene Proteins c-myc | 2 | 2014 | 113 | 0.190 |
Why?
|
| Cytochrome P-450 CYP1A1 | 1 | 2022 | 13 | 0.190 |
Why?
|
| Estrogen Receptor alpha | 3 | 2020 | 49 | 0.180 |
Why?
|
| Zeranol | 1 | 2022 | 1 | 0.180 |
Why?
|
| CpG Islands | 2 | 2020 | 219 | 0.180 |
Why?
|
| Gene Expression | 2 | 2022 | 852 | 0.180 |
Why?
|
| Polymers | 2 | 2016 | 332 | 0.170 |
Why?
|
| Adult | 12 | 2022 | 17359 | 0.170 |
Why?
|
| Genes, Modifier | 1 | 2021 | 4 | 0.170 |
Why?
|
| Li-Fraumeni Syndrome | 1 | 2021 | 7 | 0.170 |
Why?
|
| Breast Feeding | 2 | 2022 | 166 | 0.170 |
Why?
|
| Genes, Neoplasm | 1 | 2021 | 25 | 0.170 |
Why?
|
| Down-Regulation | 2 | 2013 | 324 | 0.170 |
Why?
|
| MCF-7 Cells | 3 | 2016 | 65 | 0.170 |
Why?
|
| Phenotype | 2 | 2017 | 1232 | 0.170 |
Why?
|
| Anti-Allergic Agents | 1 | 2020 | 4 | 0.170 |
Why?
|
| Protein Disulfide-Isomerases | 1 | 2020 | 15 | 0.170 |
Why?
|
| Young Adult | 5 | 2020 | 4812 | 0.160 |
Why?
|
| DNA Breaks, Double-Stranded | 1 | 2021 | 88 | 0.160 |
Why?
|
| Middle Aged | 11 | 2022 | 18273 | 0.160 |
Why?
|
| Tumor Cells, Cultured | 2 | 2020 | 426 | 0.160 |
Why?
|
| Cell Polarity | 1 | 2020 | 110 | 0.160 |
Why?
|
| Prenatal Exposure Delayed Effects | 1 | 2021 | 155 | 0.150 |
Why?
|
| Epigenesis, Genetic | 2 | 2020 | 407 | 0.150 |
Why?
|
| DNA Repair | 1 | 2021 | 262 | 0.150 |
Why?
|
| DNA Replication | 1 | 2021 | 247 | 0.150 |
Why?
|
| Gene Expression Profiling | 5 | 2019 | 794 | 0.150 |
Why?
|
| Enzyme Inhibitors | 1 | 2020 | 367 | 0.140 |
Why?
|
| Environmental Pollutants | 1 | 2020 | 97 | 0.140 |
Why?
|
| Curcumin | 2 | 2020 | 82 | 0.140 |
Why?
|
| Mitochondria | 2 | 2012 | 409 | 0.140 |
Why?
|
| Neuroblastoma | 1 | 2018 | 54 | 0.130 |
Why?
|
| Benzhydryl Compounds | 1 | 2018 | 61 | 0.130 |
Why?
|
| Quantitative Trait Loci | 1 | 2018 | 81 | 0.130 |
Why?
|
| Cell Degranulation | 3 | 2024 | 23 | 0.130 |
Why?
|
| Pyruvic Acid | 1 | 2017 | 16 | 0.130 |
Why?
|
| Prognosis | 3 | 2020 | 1785 | 0.130 |
Why?
|
| Axin Protein | 2 | 2017 | 10 | 0.130 |
Why?
|
| Metabolomics | 1 | 2017 | 63 | 0.130 |
Why?
|
| Oxidation-Reduction | 1 | 2017 | 325 | 0.120 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2018 | 373 | 0.120 |
Why?
|
| Mice, 129 Strain | 1 | 2016 | 41 | 0.120 |
Why?
|
| Adolescent | 5 | 2021 | 6306 | 0.120 |
Why?
|
| Mice, Inbred C57BL | 3 | 2025 | 3481 | 0.120 |
Why?
|
| MAP Kinase Signaling System | 1 | 2017 | 235 | 0.120 |
Why?
|
| Mastocytosis | 1 | 2015 | 2 | 0.120 |
Why?
|
| Blotting, Western | 2 | 2015 | 610 | 0.120 |
Why?
|
| Phosphorylation | 3 | 2015 | 962 | 0.110 |
Why?
|
| Neoplasm Invasiveness | 3 | 2014 | 287 | 0.110 |
Why?
|
| Histones | 1 | 2018 | 494 | 0.110 |
Why?
|
| Transforming Growth Factor beta2 | 1 | 2015 | 8 | 0.110 |
Why?
|
| Anaphylaxis | 1 | 2015 | 41 | 0.110 |
Why?
|
| S-Phase Kinase-Associated Proteins | 1 | 2014 | 7 | 0.110 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p27 | 1 | 2014 | 32 | 0.110 |
Why?
|
| Oxidative Phosphorylation | 2 | 2012 | 43 | 0.110 |
Why?
|
| Ovarian Neoplasms | 1 | 2016 | 166 | 0.110 |
Why?
|
| RANK Ligand | 1 | 2014 | 23 | 0.110 |
Why?
|
| Aged | 7 | 2021 | 14963 | 0.110 |
Why?
|
| Mutation | 2 | 2021 | 2661 | 0.110 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2015 | 211 | 0.110 |
Why?
|
| Long Interspersed Nucleotide Elements | 1 | 2014 | 18 | 0.110 |
Why?
|
| DNA, Neoplasm | 1 | 2014 | 61 | 0.100 |
Why?
|
| Epithelial-Mesenchymal Transition | 2 | 2013 | 84 | 0.100 |
Why?
|
| Parity | 1 | 2014 | 71 | 0.100 |
Why?
|
| Genes, Tumor Suppressor | 1 | 2014 | 78 | 0.100 |
Why?
|
| Glucose Transport Proteins, Facilitative | 1 | 2013 | 9 | 0.100 |
Why?
|
| Gene Deletion | 1 | 2015 | 312 | 0.100 |
Why?
|
| Bcl-2-Like Protein 11 | 1 | 2013 | 20 | 0.100 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p21 | 1 | 2013 | 58 | 0.100 |
Why?
|
| Ovalbumin | 3 | 2020 | 108 | 0.100 |
Why?
|
| Cell Line | 2 | 2015 | 2023 | 0.100 |
Why?
|
| Ovary | 1 | 2013 | 105 | 0.100 |
Why?
|
| rhoA GTP-Binding Protein | 1 | 2013 | 27 | 0.100 |
Why?
|
| Matrix Metalloproteinase 2 | 1 | 2013 | 29 | 0.100 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2013 | 129 | 0.100 |
Why?
|
| Adipose Tissue, White | 1 | 2013 | 92 | 0.100 |
Why?
|
| Biopsy | 1 | 2015 | 456 | 0.100 |
Why?
|
| Reproducibility of Results | 2 | 2026 | 1698 | 0.100 |
Why?
|
| Dietary Fats | 1 | 2014 | 180 | 0.100 |
Why?
|
| Caspase 3 | 1 | 2013 | 108 | 0.100 |
Why?
|
| Lipogenesis | 1 | 2013 | 66 | 0.100 |
Why?
|
| Matrix Metalloproteinase 9 | 1 | 2013 | 65 | 0.100 |
Why?
|
| Polymerase Chain Reaction | 1 | 2014 | 513 | 0.100 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2014 | 210 | 0.090 |
Why?
|
| Estradiol | 2 | 2018 | 259 | 0.090 |
Why?
|
| Fatty Liver | 1 | 2013 | 111 | 0.090 |
Why?
|
| Infant | 3 | 2022 | 1693 | 0.090 |
Why?
|
| Fluorocarbon Polymers | 1 | 2012 | 4 | 0.090 |
Why?
|
| Fluorobenzenes | 1 | 2012 | 6 | 0.090 |
Why?
|
| Xenograft Model Antitumor Assays | 2 | 2014 | 203 | 0.090 |
Why?
|
| Methacrylates | 1 | 2012 | 41 | 0.090 |
Why?
|
| Muramidase | 1 | 2012 | 47 | 0.090 |
Why?
|
| Body Weight | 1 | 2013 | 376 | 0.090 |
Why?
|
| Zebrafish Proteins | 1 | 2013 | 168 | 0.090 |
Why?
|
| Wnt Proteins | 1 | 2012 | 104 | 0.090 |
Why?
|
| Morphogenesis | 1 | 2012 | 120 | 0.090 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2013 | 343 | 0.090 |
Why?
|
| Immunoglobulin A | 2 | 2022 | 102 | 0.090 |
Why?
|
| DNA Damage | 1 | 2013 | 298 | 0.090 |
Why?
|
| Electron Transport Complex I | 1 | 2011 | 15 | 0.090 |
Why?
|
| Zinc Finger E-box Binding Homeobox 2 | 1 | 2011 | 1 | 0.080 |
Why?
|
| Organ Culture Techniques | 2 | 2008 | 62 | 0.080 |
Why?
|
| Mitogen-Activated Protein Kinase 3 | 1 | 2011 | 42 | 0.080 |
Why?
|
| Telomerase | 1 | 2011 | 30 | 0.080 |
Why?
|
| Homeostasis | 1 | 2013 | 378 | 0.080 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 1 | 2011 | 46 | 0.080 |
Why?
|
| Quinolines | 1 | 2011 | 47 | 0.080 |
Why?
|
| Pyrroles | 1 | 2011 | 50 | 0.080 |
Why?
|
| Disease Progression | 2 | 2019 | 1219 | 0.080 |
Why?
|
| Cell Movement | 2 | 2013 | 480 | 0.080 |
Why?
|
| Th2 Cells | 2 | 2024 | 93 | 0.080 |
Why?
|
| Pyrazoles | 1 | 2011 | 88 | 0.080 |
Why?
|
| Gene Knockdown Techniques | 1 | 2011 | 203 | 0.080 |
Why?
|
| Oxygen Consumption | 1 | 2011 | 213 | 0.080 |
Why?
|
| Immunoglobulin G | 2 | 2022 | 465 | 0.080 |
Why?
|
| MicroRNAs | 1 | 2016 | 710 | 0.080 |
Why?
|
| Cysteine-Rich Protein 61 | 1 | 2009 | 5 | 0.080 |
Why?
|
| Insulin | 1 | 2013 | 695 | 0.080 |
Why?
|
| Carcinogenesis | 2 | 2022 | 134 | 0.080 |
Why?
|
| Cyclooxygenase 2 | 1 | 2009 | 61 | 0.080 |
Why?
|
| Time Factors | 1 | 2017 | 3762 | 0.080 |
Why?
|
| Homeodomain Proteins | 1 | 2011 | 277 | 0.070 |
Why?
|
| Neovascularization, Pathologic | 1 | 2009 | 140 | 0.070 |
Why?
|
| Insulin-Like Growth Factor Binding Protein 3 | 1 | 2008 | 11 | 0.070 |
Why?
|
| Repressor Proteins | 1 | 2011 | 351 | 0.070 |
Why?
|
| In Situ Nick-End Labeling | 1 | 2008 | 47 | 0.070 |
Why?
|
| NF-kappa B | 3 | 2018 | 434 | 0.070 |
Why?
|
| Wound Healing | 1 | 2009 | 193 | 0.070 |
Why?
|
| Rats | 2 | 2022 | 1994 | 0.070 |
Why?
|
| Transforming Growth Factor beta1 | 1 | 2008 | 61 | 0.070 |
Why?
|
| Diarrhea | 2 | 2020 | 73 | 0.070 |
Why?
|
| Random Allocation | 1 | 2008 | 200 | 0.070 |
Why?
|
| Reference Values | 1 | 2008 | 327 | 0.070 |
Why?
|
| Genome, Human | 1 | 2009 | 237 | 0.070 |
Why?
|
| Tumor Microenvironment | 2 | 2020 | 182 | 0.070 |
Why?
|
| RNA, Messenger | 1 | 2013 | 1575 | 0.070 |
Why?
|
| Caspases | 1 | 2008 | 176 | 0.060 |
Why?
|
| Biomarkers | 2 | 2026 | 1480 | 0.060 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2008 | 542 | 0.060 |
Why?
|
| Disease Susceptibility | 2 | 2021 | 169 | 0.060 |
Why?
|
| Risk Factors | 4 | 2020 | 5430 | 0.060 |
Why?
|
| Cell Survival | 2 | 2018 | 587 | 0.060 |
Why?
|
| Promoter Regions, Genetic | 2 | 2020 | 687 | 0.060 |
Why?
|
| Cyclin D1 | 2 | 2017 | 17 | 0.060 |
Why?
|
| Sensitivity and Specificity | 1 | 2008 | 1163 | 0.060 |
Why?
|
| Risk | 2 | 2016 | 374 | 0.060 |
Why?
|
| Interleukin-13 | 1 | 2024 | 37 | 0.050 |
Why?
|
| Treatment Outcome | 1 | 2015 | 5791 | 0.050 |
Why?
|
| Aged, 80 and over | 3 | 2021 | 5614 | 0.050 |
Why?
|
| Transcription, Genetic | 1 | 2008 | 907 | 0.050 |
Why?
|
| Spleen | 1 | 2024 | 474 | 0.050 |
Why?
|
| Receptors, CCR7 | 1 | 2022 | 9 | 0.050 |
Why?
|
| Immunoglobulin M | 1 | 2022 | 116 | 0.050 |
Why?
|
| Rodentia | 1 | 2022 | 20 | 0.050 |
Why?
|
| Case-Control Studies | 2 | 2016 | 1141 | 0.050 |
Why?
|
| Half-Life | 2 | 2012 | 81 | 0.050 |
Why?
|
| Breast Density | 1 | 2022 | 17 | 0.050 |
Why?
|
| 9,10-Dimethyl-1,2-benzanthracene | 1 | 2022 | 4 | 0.050 |
Why?
|
| Caprylates | 1 | 2022 | 15 | 0.050 |
Why?
|
| Hormones | 1 | 2022 | 62 | 0.040 |
Why?
|
| Environment | 1 | 2022 | 125 | 0.040 |
Why?
|
| Phthalic Acids | 1 | 2022 | 41 | 0.040 |
Why?
|
| Ethiopia | 1 | 2021 | 8 | 0.040 |
Why?
|
| Spike Glycoprotein, Coronavirus | 1 | 2022 | 114 | 0.040 |
Why?
|
| Genetic Linkage | 1 | 2021 | 97 | 0.040 |
Why?
|
| Recombinational DNA Repair | 1 | 2021 | 29 | 0.040 |
Why?
|
| B-Lymphocytes | 1 | 2024 | 563 | 0.040 |
Why?
|
| Fluorocarbons | 1 | 2022 | 52 | 0.040 |
Why?
|
| Bacitracin | 1 | 2020 | 5 | 0.040 |
Why?
|
| Maternal Exposure | 1 | 2021 | 43 | 0.040 |
Why?
|
| Rutin | 1 | 2020 | 4 | 0.040 |
Why?
|
| Genetic Loci | 1 | 2021 | 116 | 0.040 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2022 | 205 | 0.040 |
Why?
|
| Neoplasm Metastasis | 1 | 2021 | 222 | 0.040 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2022 | 624 | 0.040 |
Why?
|
| Folic Acid | 1 | 2020 | 42 | 0.040 |
Why?
|
| Chromosome Mapping | 1 | 2021 | 295 | 0.040 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2024 | 639 | 0.040 |
Why?
|
| GATA3 Transcription Factor | 1 | 2020 | 16 | 0.040 |
Why?
|
| Hepatocyte Nuclear Factor 3-alpha | 1 | 2020 | 21 | 0.040 |
Why?
|
| Toxicity Tests | 1 | 2020 | 19 | 0.040 |
Why?
|
| Antibodies, Viral | 1 | 2022 | 325 | 0.040 |
Why?
|
| Hyperplasia | 1 | 2019 | 90 | 0.040 |
Why?
|
| Vaccination | 1 | 2022 | 377 | 0.040 |
Why?
|
| Hydroxamic Acids | 1 | 2018 | 29 | 0.040 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2021 | 509 | 0.040 |
Why?
|
| Histone Deacetylase Inhibitors | 1 | 2018 | 38 | 0.040 |
Why?
|
| Acetylation | 1 | 2018 | 121 | 0.040 |
Why?
|
| N-Myc Proto-Oncogene Protein | 1 | 2018 | 9 | 0.040 |
Why?
|
| Cytotoxins | 1 | 2018 | 11 | 0.040 |
Why?
|
| Mastectomy | 1 | 2018 | 56 | 0.030 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 2018 | 223 | 0.030 |
Why?
|
| Gene Regulatory Networks | 1 | 2019 | 160 | 0.030 |
Why?
|
| Bone Marrow Cells | 1 | 2018 | 237 | 0.030 |
Why?
|
| Tandem Mass Spectrometry | 1 | 2018 | 137 | 0.030 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2018 | 415 | 0.030 |
Why?
|
| Antibodies, Blocking | 1 | 2017 | 39 | 0.030 |
Why?
|
| Infant, Newborn | 1 | 2022 | 1422 | 0.030 |
Why?
|
| Epithelium | 2 | 2008 | 100 | 0.030 |
Why?
|
| Receptors, IgE | 1 | 2016 | 6 | 0.030 |
Why?
|
| Body Mass Index | 1 | 2020 | 897 | 0.030 |
Why?
|
| Maximum Tolerated Dose | 1 | 2016 | 40 | 0.030 |
Why?
|
| Adoptive Transfer | 1 | 2016 | 145 | 0.030 |
Why?
|
| Adipose Tissue | 1 | 2018 | 299 | 0.030 |
Why?
|
| Interleukin-6 | 1 | 2017 | 323 | 0.030 |
Why?
|
| Genetic Variation | 1 | 2018 | 394 | 0.030 |
Why?
|
| Interleukin-1beta | 1 | 2017 | 274 | 0.030 |
Why?
|
| Child, Preschool | 1 | 2021 | 2061 | 0.030 |
Why?
|
| Cohort Studies | 1 | 2022 | 2619 | 0.030 |
Why?
|
| Mice, SCID | 1 | 2016 | 518 | 0.030 |
Why?
|
| Cyclin-Dependent Kinase 2 | 1 | 2014 | 19 | 0.030 |
Why?
|
| Mice, Inbred NOD | 1 | 2016 | 526 | 0.030 |
Why?
|
| Neoplasm Grading | 1 | 2014 | 94 | 0.030 |
Why?
|
| Protein Isoforms | 1 | 2015 | 202 | 0.030 |
Why?
|
| Serine | 1 | 2014 | 90 | 0.030 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2018 | 730 | 0.030 |
Why?
|
| Cluster Analysis | 1 | 2014 | 261 | 0.030 |
Why?
|
| Lymphocyte Activation | 1 | 2016 | 752 | 0.020 |
Why?
|
| 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine | 1 | 2013 | 6 | 0.020 |
Why?
|
| Matrix Metalloproteinase 1 | 1 | 2013 | 9 | 0.020 |
Why?
|
| Up-Regulation | 1 | 2014 | 374 | 0.020 |
Why?
|
| Intestinal Mucosa | 1 | 2015 | 249 | 0.020 |
Why?
|
| Carcinogens, Environmental | 1 | 2012 | 6 | 0.020 |
Why?
|
| Transfection | 1 | 2014 | 701 | 0.020 |
Why?
|
| Micrococcus | 1 | 2012 | 3 | 0.020 |
Why?
|
| Esters | 1 | 2012 | 16 | 0.020 |
Why?
|
| Cell Cycle | 1 | 2014 | 398 | 0.020 |
Why?
|
| Enzyme Stability | 1 | 2012 | 47 | 0.020 |
Why?
|
| Odds Ratio | 1 | 2014 | 754 | 0.020 |
Why?
|
| Polymerization | 1 | 2012 | 36 | 0.020 |
Why?
|
| Molecular Weight | 1 | 2012 | 193 | 0.020 |
Why?
|
| Area Under Curve | 1 | 2012 | 149 | 0.020 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2012 | 278 | 0.020 |
Why?
|
| Child | 1 | 2021 | 4612 | 0.020 |
Why?
|
| Gamma Rays | 1 | 2011 | 32 | 0.020 |
Why?
|
| Microscopy, Fluorescence | 1 | 2012 | 401 | 0.020 |
Why?
|
| RNA Interference | 1 | 2014 | 643 | 0.020 |
Why?
|
| Particle Size | 1 | 2012 | 428 | 0.020 |
Why?
|
| Age Factors | 1 | 2014 | 1585 | 0.020 |
Why?
|
| Cross-Sectional Studies | 1 | 2016 | 2704 | 0.020 |
Why?
|
| Base Sequence | 1 | 2011 | 1329 | 0.020 |
Why?
|
| Early Growth Response Protein 1 | 1 | 2008 | 17 | 0.020 |
Why?
|
| 14-3-3 Proteins | 1 | 2008 | 20 | 0.020 |
Why?
|
| Cell Line, Transformed | 1 | 2008 | 97 | 0.020 |
Why?
|
| Ovariectomy | 1 | 2008 | 103 | 0.020 |
Why?
|
| Mice, Mutant Strains | 1 | 2008 | 301 | 0.020 |
Why?
|
| Molecular Sequence Data | 1 | 2011 | 1979 | 0.020 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2008 | 297 | 0.020 |
Why?
|
| Surveys and Questionnaires | 1 | 2015 | 2763 | 0.020 |
Why?
|
| Blotting, Northern | 1 | 2005 | 152 | 0.010 |
Why?
|
| Male | 1 | 2024 | 31056 | 0.010 |
Why?
|
| Neoplasms | 1 | 2011 | 1367 | 0.010 |
Why?
|